Amneal Pharmaceuticals, Inc. is set to expand its reach as it develops, manufactures, markets and distributes a variety of pharmaceutical products globally. The company is comprised of three segments, namely Generics, Specialty, and AvKARE, and offers a diverse range of products including generics, injectables, biosimilars, and specialty branded pharmaceuticals. The Generics segment alone provides a broad portfolio of products ranging from oral solid, powder and liquid to transdermal patch and topical treatments. Meanwhile, the Specialty segment primarily focuses on central nervous and endocrine disorders, with a strong emphasis on Parkinson's disease through the promotion, sale and distribution of Rytary, a drug which combats Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism. The AvKARE segment primarily distributes pharmaceuticals, medical and surgical products, and services to government agencies as well as to the Department of Defense and Veterans Affairs. The company markets its products through a variety of channels including wholesalers, distributors, hospitals, chain pharmacies and individual pharmacies. Amneal Pharmaceuticals was founded in 2002 and is based in Bridgewater, New Jersey.
Amneal Pharmaceuticals's ticker is AMRX
The company's shares trade on the NYSE stock exchange
They are based in Bridgewater, New Jersey
There are 5001-10,000 employees working at Amneal Pharmaceuticals
It is amneal.com
Amneal Pharmaceuticals is in the Healthcare sector
Amneal Pharmaceuticals is in the Drug Manufacturers - Other industry
The following five companies are Amneal Pharmaceuticals's industry peers: